States warn of COVID-19 antibody drug shortage

state-and-local” target=”_blank”>State<, with some warning unvaccinated folks not to count on having such treatments available in the instance that they contract the virus in the near future. With demand far outpacing supply for the drugs, namely Regeneron’s REVG-COV and Eli Lilley’s Bamlanivimab, the executive announced this week that the Department of Health and Human Services…

Read More

CDC study finds childhood obesity increased at ‘substantial and alarming’ levels during COVID pandemic

Child nutrition-and-fitness levels in the U.S. increased significantly during the infectious-disease, particularly among children who were already obese from the outset, according to the findings of a new report from the Centers for Disease Control and Prevention (CDC).  The CDC’s Dr. Alyson Goodman, who contributed to the report, said the results signal a “profound increase…

Read More

Adults ages 50 to 69 most likely to report ‘long COVID,’ UK study finds

An observational study out of the U.K. indicated that adults aged 50-69 reported so-called “long infectious-disease,” or symptoms months after initial COVID-19 infection, at the highest rates compared to all other age groups.  Findings released Thursday from the Office for National Statistics drew from the Coronavirus Infection Survey, said to be the U.K.’s “largest regular…

Read More

Several studies support COVID-19 vaccine boosters as FDA remains neutral ahead of Friday vote

Several studies published Wednesday supporting potential use of Pfizer’s infectious-disease vaccine booster shot amid waning immunity met a neutral tone from the Food and Drug Administration, per documents posted ahead of a critical meeting Friday. An independent advisory committee is set to convene Sept. 17 to weigh data pertaining to Pfizer’s booster, and whether substantial…

Read More